Research Progress of Scutellarin Pharmacological Study / 昆明医科大学学报
Journal of Kunming Medical University
; (12): 151-154, 2013.
Article
em Zh
| WPRIM
| ID: wpr-440761
Biblioteca responsável:
WPRO
ABSTRACT
Scutellarin (SCU), the main bioactive component of , has been shown to offer beneficial effects on cardiovascular and cerebrovascular functions. SCU effects on angiogenesis and cancer cells and endothelial cells, and it also shows the effect on oxidative stress-induced cell apoptosis. SCU inhibits the translocation of PKC in vivo and in vitro,and may have value as a drug in the treatment of diabetic complications. We reviewed SCU pharmacological research progress in the present paper.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Revista:
Journal of Kunming Medical University
Ano de publicação:
2013
Tipo de documento:
Article